ResearcherUniversity of North Carolina at Chapel HillActive in the last 2 years
Cyrus Vaziri
Matched on ORCID iD 0000-0002-3081-8685; OpenAlex author ID A5046474582. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 2 papers
Papers 4
- TRIP13 protects pancreatic cancer cells against intrinsic and therapy-induced DNA replication stress. Last author DOI 10.1093/narcan/zcaf009↗
- TRIP13 protects pancreatic cancer cells against intrinsic and therapy-induced DNA replication stress Last author DOI 10.1101/2025.01.26.634889↗
- VCP/p97, a pleiotropic protein regulator of the DNA damage response and proteostasis, is a potential therapeutic target in KRAS-mutant pancreatic cancer. Co-author DOI 10.18632/genesandcancer.231↗
- Irreversible JNK1-JUN inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU/FOLFOX chemotherapy. Co-author DOI 10.1172/jci.insight.129905↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Channing J. Der · 3 shared papers, 2023–2025 · strength 0.65
- Paper TRIP13 protects pancreatic cancer cells against intrinsic and therapy-induced DNA replication stress. DOI 10.1093/narcan/zcaf009↗
- Paper TRIP13 protects pancreatic cancer cells against intrinsic and therapy-induced DNA replication stress DOI 10.1101/2025.01.26.634889↗
- Paper VCP/p97, a pleiotropic protein regulator of the DNA damage response and proteostasis, is a potential therapeutic target… DOI 10.18632/genesandcancer.231↗
- Jay Ramanlal Anand · 2 shared papers, 2025 · strength 0.47
- Jeremy Purvis · 2 shared papers, 2025 · strength 0.47
- Ye S. Lee · 1 shared paper, 2023 · strength 0.18
- Kirsten L. Bryant · 1 shared paper, 2023 · strength 0.18
- Adrienne D. Cox · 1 shared paper, 2023 · strength 0.18
- Jennifer E. Klomp · 1 shared paper, 2023 · strength 0.18
- Clint A. Stalnecker · 1 shared paper, 2023 · strength 0.18
- Craig M. Goodwin · 1 shared paper, 2023 · strength 0.18
- Matthew B. Lipner · 1 shared paper, 2020 · strength 0.09
- Gary L. Johnson · 1 shared paper, 2020 · strength 0.09
- Naim U. Rashid · 1 shared paper, 2020 · strength 0.09
- Yi Xu · 1 shared paper, 2020 · strength 0.09
- Richard A. Moffitt · 1 shared paper, 2020 · strength 0.09
- Lee M. Graves · 1 shared paper, 2020 · strength 0.09
- Jen Jen Yeh · 1 shared paper, 2020 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.